Where Does Wall Street Think ORIC Pharmaceuticals Inc (ORIC) Stock Will Go?

Wall Street is positive on ORIC Pharmaceuticals Inc (ORIC). On average, analysts give the stock a Buy rating. The average price target is $19, which means analysts expect the stock to add by 365.69% over the next twelve months. That average ranking earns the stock an Analyst Rating of 29, which is better than 29% of stocks based on data compiled by InvestorsObserver.

Wall Street analysts are rating ORIC a Buy today. Find out what this means to you and get the rest of the rankings on ORIC!

See Full ORIC Report

Why are Analyst Ratings Important?

Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve. InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.

What's Happening With ORIC Pharmaceuticals Inc Stock Today?

ORIC Pharmaceuticals Inc (ORIC) stock is down -9.33% while the S&P 500 has risen 0.27% as of 11:02 AM on Monday, Apr 18. ORIC is lower by -$0.42 from the previous closing price of $4.50 on volume of 272,243 shares. Over the past year the S&P 500 has risen 5.80% while ORIC is lower by -80.62%. ORIC lost -$2.07 per share the over the last 12 months. Click Here to get the full Stock Report for ORIC Pharmaceuticals Inc stock.